Big Pharma

R&D Efficiency

Explore the innovation efficacy of leading publicly traded pharma companies.

Our app tracks the relationship between R&D spending and the FDA-approved New Molecular Entities (NMEs) and Biologic License Applications (BLAs), offering comprehensive insights into each company's R&D Return on Investment.

R&D ROI: Industry Snapshot (2000-2022)

Distribution of Pharmaceutical Companies' R&D Efficiency and Revenue per FDA-Approved Non-generic Drug across Observed Period, Segmented by Performance Levels

R&D ROI

Comparative Analysis of Pharmaceutical Companies' R&D Efficiency in Generating Revenue from FDA-Approved Non-generic Drugs

R&D Efficacy

Comparative Analysis of Pharmaceutical Companies' R&D Investment with FDA Approvals

Internal R&D Efficiency

Internal R&D efficiency overview

Selected company

Experience the power of data visualization with eyesON interactive visualizers.

Explore more and discover insights you never knew existed.